77 related articles for article (PubMed ID: 582537)
1. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems.
Riley RL; Mir GN; Rowles GS; Sperow JW; Alioto RL; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Krebs JB; Eash JR; Rowles GS; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1454-61. PubMed ID: 89850
[TBL] [Abstract][Full Text] [Related]
3. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide.
Mir GN; Alioto RL; Sperow JW; Eash JR; Krebs JB; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1448-54. PubMed ID: 582536
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Riley RL; Alioto RL; Nuss GW; Chou BJ; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1466-70. PubMed ID: 582538
[TBL] [Abstract][Full Text] [Related]
5. Toxicity studies on lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Chou BJ; Mir GN; Brown WR; Rapp WR; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1471-6. PubMed ID: 113015
[TBL] [Abstract][Full Text] [Related]
6. Analytical-physical profile of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Zalipsky JJ; Won CM; Patel DM
Arzneimittelforschung; 1978; 28(8a):1441-7. PubMed ID: 582535
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
[TBL] [Abstract][Full Text] [Related]
8. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the safety and effectiveness of WHR-1142A in the treatment of non-specific acute diarrhea].
Heredia Díaz JG; Alcántara I; Solís A
Rev Gastroenterol Mex; 1979; 44(4):167-73. PubMed ID: 394268
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
15. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
Komarek J
Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
[TBL] [Abstract][Full Text] [Related]
16. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1 (H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69/183). Part II: Effect on cardiac dynamics.
Srimal RC; Mason DF; Dhawan BN
Arzneimittelforschung; 1978; 28(7):1092-5. PubMed ID: 582695
[TBL] [Abstract][Full Text] [Related]
19. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
